The pharmaceutical world is witnessing a remarkable shift in blood sugar management with the arrival of GLP-1 patches. These systems offer a possibly more comfortable alternative to shots of GLP-1 receptor agonists, reducing the requirement of daily needle pricks. The approach releases the medica